Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
Yoshiyama T, Saito Y, Masuda K, Nakanishi Y, Kido Y, Uchimura K, Mitarai S, Suzuki T, Nakagama Y, Kubota H, Satomi M, Uchikoba S, Ohnishi M, Wakita T, Kato S, Kato K.
Yoshiyama T, et al.
Emerg Infect Dis. 2021 Feb;27(2):628-631. doi: 10.3201/eid2702.204088.
Emerg Infect Dis. 2021.
PMID: 33496235
Free PMC article.